Shri Ahimsa Naturals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Shri Ahimsa Naturals Limited (Formly Shri Ahimsa Mines And Minerals Ltd.) is presently engaged in the extraction, manufacturing, of Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE) and Crude Caffeine along with trading of other herbal extracts. Their products find their application in the food & beverage, nutraceuticals, cosmetics and pharmaceutical industries due to their health benefits. 

Shri Ahimsa Naturals, an Book Built Issue amounting to ₹ 73.81 Crores, consisting an Fresh Issue of 42.03 Lakh Shares worth ₹ 50.02 Crores and an Offer for Sale of 19.92 Lakh Shares totaling to ₹ 23.79 CroresThe subscription period for the Shri Ahimsa Naturals IPO opens on March 25, 2025, and closes on March 27, 2025. The allotment is expected to be finalized on or about Friday, March 28, 2025, and the shares will be listed on the NSE SME with a tentative listing date set on or about Thursday, April 03, 2025.

The Share Price Band of Shri Ahimsa Naturals IPO is set at ₹ 113 to ₹ 119 per equity share. The Market Capitalisation of the Shri Ahimsa Naturals Limited at IPO price of ₹ 119 per equity share will be ₹ 277.62 Crores. The lot size of the IPO is 1,200 shares. Retail investors are required to invest a minimum of ₹ 1,42,800, while the minimum investment for High-Net-Worth Individuals (HNIs) is 2 lots (2,400 shares), amounting to ₹ 2,85,600.

Srujan Alpha Capital Advisors LLP is the book running lead manager of the Shri Ahimsa Naturals IPO, while Cameo Corporate Services Limited is the registrar for the issue. Choice Equity Broking Private Limited is the Market Maker for Shri Ahimsa Naturals IPO.

Shri Ahimsa Naturals Limited IPO GMP Today
The Grey Market Premium of Shri Ahimsa Naturals Limited IPO is expected to be ₹ 0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Shri Ahimsa Naturals Limited IPO Live Subscription Status Today: Real-Time Update
Shri Ahimsa Naturals IPO will be open for its subscription on 25 March, 2025.

Shri Ahimsa Naturals Limited Day Wise IPO GMP Trend

Date

IPO Price

Expected Listing Price

GMP

Last Updated 

20 March 2025 ₹ 119 ₹ 119 ₹ 0 (0.00%) 02:00 PM; 20 Mar 2025


Shri Ahimsa Naturals IPO Anchor Investors Report
Shri Ahimsa Naturals has raised ₹ 20.87 Crores from Anchor Investors at a price of ₹ 119 per shares in consultation of the Book Running Lead Managers. The company allocated 17,54,400 equity shares to the Anchor Investors. Check Full List of Shri Ahimsa Naturals Anchor Investor List.

Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion

Shri Ahimsa Naturals Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Shri Ahimsa Naturals IPO allotment date is 28 March, 2025, Friday. Shri Ahimsa Naturals IPO Allotment will be out on 28 March, 2025 and will be live on Registrar Website from the allotment date.
 Check Shri Ahimsa Naturals IPO Allotment Status hereHere's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Shri Ahimsa Naturals Limited IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Shri Ahimsa Naturals Limited IPO
Shri Ahimsa Naturals proposes to utilise the Net Proceeds towards the following objects: 
1. ₹ 3,500.00 Lakhs is required for Investment in their Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL) for setting up a manufacturing facility at Sawarda, Jaipur, Rajasthan.
2. General Corporate Purpose

Refer to Shri Ahimsa Naturals Limited RHP for more details about the Company.

Shri Ahimsa Naturals IPO Details

IPO Date March 25, 2025 to March 27, 2025
Listing Date April 03, 2025
Face Value ₹ 10
Price ₹ 113 to ₹ 119 per share
Lot Size 1,200 Equity Shares
Total Issue Size 62,02,800 Equity Shares (aggregating up to ₹ 73.81 Cr)
Fresh Issue 42,03,600 Equity Shares (aggregating up to ₹ 50.02 Cr)
Offer for Sale 19,99,200 Equity Shares (aggregating up to ₹ 23.79 Cr)
Issue Type Book Built Issue
Listing At NSE SME
Share holding pre issue 1,91,26,500
Share holding post issue 2,33,30,100

Shri Ahimsa Naturals IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1,200 ₹1,42,800
Retail (Max) 1 1,200 ₹1,42,800
S-HNI (Min) 2 2,400 ₹2,85,600
S-HNI (Max) 7 8,400 ₹9,99,600
B-HNI (Min) 8 9,600 ₹11,42,400

Shri Ahimsa Naturals IPO Timeline (Tentative Schedule)

IPO Open Date March 25, 2025
IPO Close Date March 27, 2025
Basis of Allotment March 28, 2025
Initiation of Refunds April 02, 2025
Credit of Shares to Demat April 02, 2025
Listing Date April 03, 2025
Cut-off time for UPI mandate confirmation 5 PM on March 27, 2025

Shri Ahimsa Naturals IPO Reservation

Investor Category Shares Offered Reservation %
QIB Portion 11,70,000 Not More than 50% of the Issue
Non-Institutional Investor Portion 8,84,400 Not Less than 15% of the Issue
Retail Shares Offered 20,82,000 Not Less than 35% of the Issue
Market Maker Portion 3,12,000 5.30% of the Net Issue
Achor Investor Portion 17,54,400 Allotted from QIB Portion

Shri Ahimsa Naturals IPO Promoter Holding

Share Holding Pre Issue 94.22%
Share Holding Post Issue 68.68%

Shri Ahimsa Naturals IPO Subscription Status

Investor Category Shares Offered Shares Bid For No oF Times Subscribed
Qualified Institutional Buyers (QIB) 11,70,000 - 0.00
Non Institutional Investors(NIIS) 11,96,400 - 0.00
Retail Individual Investors (RIIs) 20,82,000 - 0.00
Total 44,48,400 - 0.00

About Shri Ahimsa Naturals Limited

Business Overview

Shri Ahimsa Naturals Company, established in 1990, specializes in the extraction and manufacturing of Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, along with trading various herbal extracts. These products serve the food & beverage, nutraceuticals, cosmetics, and pharmaceutical industries due to their health benefits.

The company processes crude caffeine sourced from decaffeination plants in Vietnam, Mexico, and other regions. Initially focused on Caffeine Anhydrous Natural, it expanded in 2018 by developing a process to extract GCE from crude caffeine. Further diversifying, the company introduced herbal extracts in 2021 to meet rising demand. Since 2022, production of Crude Caffeine from Tea and Coffee waste has commenced for both open market sales and captive consumption.

An Export Oriented Unit, the company supplies its products to 14+ countries, including USA, Germany, South Korea, UK, and Thailand. As on date of RHP, the Company have 73 employees and they do not have any contractual employees in the Company. The Banker to the Company is Canara Bank Limited.

Industry Analysis

Indian Chemical Industry: A Key Driver of Economic Growth

The Indian chemical industry is a vital sector comprising both small-scale and large-scale enterprises. With initiatives like the "Make in India" program gaining momentum, the industry is witnessing significant investments, innovations, and infrastructure development.

As one of the oldest industries in India, the chemical sector plays a crucial role in industrial and agricultural development, serving as the backbone for various downstream industries such as textiles, paper, paints, soaps, detergents, pharmaceuticals, personal care, automotive, and food processing. The increasing pace of industrial activity has further propelled demand for chemicals, driving international trade.

India’s chemical industry, covering over 80,000 commercial products, is highly diversified and can be broadly classified into:
i. Bulk Chemicals
ii. Specialty Chemicals
iii. Agrochemicals
iv. Petrochemicals
v. Polymers
vi. Fertilizers

Market Size & Growth Projections

  • The Indian chemical sector, valued at $220 billion in 2022, is projected to grow to $300 billion by 2025 and $1 trillion by 2040.

  • Demand for chemicals is expected to expand at a CAGR of 9% by 2025, contributing $383 billion to India’s GDP by 2030.

  • India's specialty chemicals market, accounting for 20% of the global $4 trillion chemical industry, is anticipated to grow at a CAGR of 12%, reaching $64 billion by 2025.

  • The China+1 strategy and growing domestic demand are expected to drive revenue growth of 18–20% in 2022 and 14–15% in 2023.

To support this growth, an estimated ₹8 lakh crore ($107.38 billion) investment is planned in the chemicals and petrochemicals sector by 2025. The government is also introducing a Production-Linked Incentive (PLI) scheme and revising the Petroleum, Chemicals, and Petrochemicals Investment Region (PCPIR) guidelines to attract further investments.


Caffeine Anhydrous: A Growing Market with Expanding Applications

Caffeine Anhydrous is a concentrated, dehydrated form of caffeine, widely used in energy drinks, weight loss supplements, and performance-enhancing products. The term "anhydrous" means "without water", referring to its purified and highly potent nature. It acts as a nervous system stimulant, improving alertness and athletic performance.

Caffeine can be derived from two sources:
i. Natural Caffeine – Extracted from plants like tea leaves, coffee beans, cocoa beans, and guarana berries.
ii. Synthetic Caffeine – Chemically synthesized from urea and chloroacetic acid, often found in energy drinks, soft drinks, and supplements.

Market Trends & Consumer Preferences

  • With rising health awareness, demand for organic and natural caffeine is increasing.

  • Weight loss supplements and sports nutrition are key growth areas due to obesity concerns.

  • Consumers are shifting towards clean-label products, preferring low-calorie beverages and organic energy sources.

Global Market Overview

  • The Caffeine Anhydrous market was valued at $622.4 million in 2023 and is expected to reach $881.5 million by 2030, growing at a CAGR of 6.88% (2024-2030).

  • North America dominates the market due to high awareness, a strong presence of pharmaceutical and dietary supplement industries, and increased consumption of energy drinks.

  • Asia-Pacific is emerging as a key market, driven by:

    • China’s dominance in synthetic caffeine production

    • Rising demand for functional beverages in India, Indonesia, and Vietnam

    • Expanding pharmaceutical and personal care applications

India’s Role in the Global Anhydrous Caffeine Market

India is a leading exporter of Caffeine Anhydrous to Bangladesh, the USA, and Russia. Major export hubs include:
i. Nhava Sheva Sea Port ($44.69 million)
ii. Delhi Air Cargo ($6.60 million)
iii. Bangalore ICD ($3.01 million)

Opportunities & Challenges

Opportunities

  • Expansion in nutraceuticals, pharmaceuticals, and energy drink markets

  • Growing demand for organic and clean-label caffeine products

  • Rising e-commerce penetration, increasing product availability

Challenges

  • Health concerns related to overconsumption, leading to regulatory scrutiny

  • Price fluctuations in raw materials

  • Competition from synthetic caffeine manufacturers in China

In conclusion, with rising consumer awareness, evolving lifestyle choices, and increasing demand for energy-boosting and weight-loss supplements, the Caffeine Anhydrous market is set for strong growth. India, as a key player in exports and production, has a strategic advantage in catering to the expanding global demand.

Business Strengths

1. Experienced Promoters & Management Team
A seasoned leadership team with deep industry expertise ensures efficient procurement, cost-effective manufacturing, and strong customer relationships. Decades of experience navigating market fluctuations provide a competitive edge for expansion and sustainability.

2. Technology-Driven Manufacturing & R&D Capabilities
Operating from a state-of-the-art facility in Jaipur, Rajasthan, with an installed capacity of 270 MTPA of Caffeine Anhydrous Natural and 200 MTPA of Green Coffee Bean Extracts. An in-house R&D and Quality Lab drives continuous product enhancement and process efficiency.

3. Commitment to Quality Service
A focus on timely deliveries and stringent quality checks ensures minimal product rejection and high customer retention. A structured order verification system maintains consistency, fostering long-term customer loyalty.

4. Strong Client Relationships
Over three decades of operations have built long-standing customer relationships. A customer-centric approach and adherence to specifications have enhanced market presence and business growth.

5. Reliable Supplier Network
Established relationships with crude caffeine suppliers ensure timely, high-quality raw material procurement. A personalized approach and experienced management support a stable and efficient supply chain.

Business Strategies

1. Expansion of Manufacturing Capacities
Manufacturing facilities in Bagru, Jaipur, will be expanded to meet increasing demand. A new facility at Sawarda, Jaipur, under wholly owned subsidiary Shri Ahimsa Healthcare Private Limited, will add 700 MTPA of Caffeine Anhydrous Natural, 300 MTPA of Green Coffee Bean Extract, and 63 MTPA of Crude Caffeine. This expansion will scale operations, attract new customers, and enhance market reach.

2. Global Market Expansion
As an export-oriented company, increasing market penetration in existing geographies and expanding into new regions remains a key strategy. Strengthening local market presence, acquiring new customers, and maintaining a high standard of product quality will drive growth and diversification.

3. Investment in Research & Development
Continuous investment in technology, R&D, and advanced machinery enhances operational efficiency, reduces costs, and improves production output. Upgrading to cutting-edge technology ensures high-quality manufacturing, economies of scale, and streamlined business operations.

4. Supplier Base Expansion
Diversifying the supplier base reduces dependency on limited vendors, optimizes procurement costs, and ensures an uninterrupted supply chain. Establishing relationships with multiple suppliers enhances negotiation power, risk mitigation, and overall production efficiency.

5. Increase in Sales Volume
Scaling up operational capacities and expanding into new markets will drive sales growth. Strategic investments in production, distribution, and market reach will enhance profitability, improve production margins, and solidify market leadership


Business Risk Factors and Concerns

1. Potential Delays in Manufacturing Expansion
An investment of ₹3,500 lakhs from the issue proceeds is allocated to establish a new manufacturing unit under its wholly owned subsidiary, Shri Ahimsa Healthcare Private Limited. Any delays in procurement, equipment installation, or civil works may result in cost and time overruns.

2. Fluctuations in Raw Material Prices
Crude Caffeine, a primary raw material, contributes significantly to production costs, accounting for up to 52.11% of net revenue in recent financial years. Price volatility, driven by external market factors, poses risks to profitability, especially without long-term supply agreements. Passing on cost increases to consumers may affect demand and market competitiveness.

3. Compliance Risks with Industrial Lease Terms
The Rajasthan State Industrial Development and Investment Corporation (RIICO) has granted a 99-year leasehold for an industrial plot in Bagru, Jaipur, which houses the registered office and manufacturing unit. Non-compliance with lease conditions or outstanding dues from previous allottees could lead to financial liabilities and potential legal consequences.

4. Dependence on Third-Party Logistics
The company relies on third-party transport providers for raw material procurement and product distribution, both domestically and internationally. Any disruptions, including cost hikes or transportation strikes, could impact supply chain efficiency and business continuity.

Shri Ahimsa Naturals faces key business risks, including potential delays in manufacturing expansion, raw material price fluctuations, compliance requirements for leased industrial land, and reliance on third-party logistics. These factors could impact operational efficiency, financial stability, and overall business growth.

Shri Ahimsa Naturals Limited Financial Information (Restated Consolidated)

Amount in (₹ in Lakh)

Period Ended Sep 30, 2024 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Reserve of Surplus 8,054.00 6,556.95 5,998.97 2,178.17
Total Assets 11,138.75 10,315.21 7,412.67 4,033.98
Total Borrowings 484.78 1,382.78 342.54 636.29
Fixed Assets 4,395.95 3,970.41 2,819.96 2,063.91
Cash 704.42 583.73 955.66 264.83
Net Borrowing -219.64 7,797.69 -613.12 371.46
Revenue 4,137.12 7,870.39 10,613.98 5,894.23
EBITDA 1,438.88 2,742.21 5,246.20 1,812.69
PAT 974.45 1,866.73 3,820.80 1,102.15
EPS 5.25 10.19 20.85 6.79

Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in BUSINESS STANDARD
.

Key Performance Indicator

KPI Values
EPS Pre IPO (Rs.) ₹10.19
EPS Post IPO (Rs.) ₹8.00
P/E Pre IPO 11.68
P/E Post IPO 14.87
ROE 22.25%
ROCE 25.69%
P/BV 1.85
Debt/Equity 0.07
RoNW 22.25%

Shri Ahimsa Naturals Limited IPO Peer Comparison

Company Name EPS ROCE ROE P/E (x) P/Bv Debt/Equity RoNW (%)
Shri Ahimsa Naturals Limited ₹ 8.00 25.69 % 22.25 % 14.87 1.85 0.07 22.25 %
There are no Listed Peer Companies in India which can be compared with Shri Ahimsa Naturals. % % - - - %
Shri Ahimsa Naturals Limited Contact Details

SHRI AHIMSA NATURALS LIMITED

E-94, RIICO Industrial Area, Bagru, Ext. Bagru-303007, Jaipur, Rajasthan, India.
Contact Person : Ms. Aayushi Jain
Telephone : 0141-2202482
Email ID : info@shriahimsa.com
Website : 
https://www.naturalcaffeine.co.in/

Shri Ahimsa Naturals IPO Registrar and Lead Manager(s)

Registrar : Cameo Corporate Services Limited
Telephone : +91-44-40020700, 28460390
Contact Person : Mr. K. Sreepriya
Email ID : ipo@cameoindia.com
Website : 
https://cameoindia.com/

Lead Manager : Srujan Alpha Capital Advisors LLP
Telephone : +91 22 4603 0709
Contact Person : Mr. Jinesh Doshi
Email ID : jinesh@srujanalpha.com
Website : 
https://www.srujanalpha.com/

Shri Ahimsa Naturals IPO Review

Shri Ahimsa Naturals Limited (Formly Shri Ahimsa Mines And Minerals Ltd.) is presently engaged in the extraction, manufacturing, of Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE) and Crude Caffeine along with trading of other herbal extracts. Their products find their application in the food & beverage, nutraceuticals, cosmetics and pharmaceutical industries due to their health benefits. 

The Company is led by the Individual Promoters namely Mr. Nemi Chand Jain, Mr. Amit Jain, Mrs.Sumitra Jain and Mr. Sumit Jain. Mrs. Prerna Jain. Their Individual Promoters, except for Mrs. Sumitra Jain and Mrs. Prerna Jain, have an extensive experience in the industry in which they operate and have been intimately involved in the business.

The Revenues from operations for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 5,894.23 Lakh, ₹  10,613.98 Lakh, ₹  7,870.39 Lakh and ₹ 4,137.12 Lakh respectively. The EBITDA for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 1,438.88 Lakh, ₹ 2,742.21 Lakh, ₹ 5,246.20 Lakh, and ₹ 1,812.69 Lakh, respectively. The Profit after Tax for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 974.45 Lakh, ₹ 1,866.73 Lakh, ₹ 3,820.80 Lakh, and ₹ 1,102.15 Lakh respectively. This indicates a steady growth in financial performance.

The Company Key Performance Indicates the pre-issue EPS of ₹ 10.19 and post-issue EPS of ₹ 8.00 for FY24. The pre-issue P/E ratio is 11.68x, while the post-issue P/E ratio is 14.87x. The company's ROCE for FY24 is 25.69%, ROE for FY24 is 22.25% and RoNW 22.25%. The Annualised EPS based on the latest financial data is ₹ 10.5 and PE ratio is 11.33x. These metrics suggest that the IPO is fairly priced.

The Grey Market Premium (GMP) of Shri Ahimsa Naturals showing listing gains of 0.00 %. Given the company's financial performance and the valuation of the IPO, we recommend Investors to Avoid to the Shri Ahimsa Naturals Limited IPO for Listing gain.


Disclaimer: The information provided in this IPO review is for educational and informational purposes only and should not be construed as financial advice or an offer to buy or sell securities. The review must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. The content is based on publicly available information and market perceptions as of the date of publication and is subject to change. Neither the author nor the website is responsible for any losses or damages arising from the use of this information. 

About the Author

 CA Abhay Kumar (Also known as  CA Abhay Varn) is a qualified Chartered Accountant by profession and cleared CA at age 21. He is a SEBI Registered Research Analyst with Registration Number - INH300008465. He Possesses 8+ years of experience in the Stock Market Field and has also worked in Big CA firms during the training period. He is good at Technical analysis and Fundamental Analysis and uses both Technical and Fundamental analysis along with five other important factors that affect the movement of the Market namely Global Market Analysis, Upcoming Event Analysis, Institutional Money Analysis, Derivative Data Analysis, and Emotions and Sentiment of Traders and Investors in his Framework called - Technical Fundamental GUIDE to find the winning Trades.

10,613.98 Lakh, ₹  7,870.39 Lakh and ₹ 4,137.12 Lakh respectively. The EBITDA for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 1,438.88 Lakh, ₹ 2,742.21 Lakh, ₹ 5,246.20 Lakh, and ₹ 1,812.69 Lakh, respectively. The Profit after Tax for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 974.45 Lakh, ₹ 1,866.73 Lakh, ₹ 3,820.80 Lakh, and ₹ 1,102.15 Lakh respectively. This indicates a steady growth in financial performance.

The Company Key Performance Indicates the pre-issue EPS of ₹ 10.19 and post-issue EPS of ₹ 8.00 for FY24. The pre-issue P/E ratio is 11.68x, while the post-issue P/E ratio is 14.87x. The company's ROCE for FY24 is 25.69%, ROE for FY24 is 22.25% and RoNW 22.25%. The Annualised EPS based on the latest financial data is ₹ 10.5 and PE ratio is 11.33x. These metrics suggest that the IPO is fairly priced.

The Grey Market Premium (GMP) of Shri Ahimsa Naturals showing listing gains of 0.00 %. Given the company's financial performance and the valuation of the IPO, we recommend Investors to Avoid to the Shri Ahimsa Naturals Limited IPO for Listing gain.


Disclaimer: The information provided in this IPO review is for educational and informational purposes only and should not be construed as financial advice or an offer to buy or sell securities. The review must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. The content is based on publicly available information and market perceptions as of the date of publication and is subject to change. Neither the author nor the website is responsible for any losses or damages arising from the use of this information. 

About the Author

 CA Abhay Kumar (Also known as  CA Abhay Varn) is a qualified Chartered Accountant by profession and cleared CA at age 21. He is a SEBI Registered Research Analyst with Registration Number - INH300008465. He Possesses 8+ years of experience in the Stock Market Field and has also worked in Big CA firms during the training period. He is good at Technical analysis and Fundamental Analysis and uses both Technical and Fundamental analysis along with five other important factors that affect the movement of the Market namely Global Market Analysis, Upcoming Event Analysis, Institutional Money Analysis, Derivative Data Analysis, and Emotions and Sentiment of Traders and Investors in his Framework called - Technical Fundamental GUIDE to find the winning Trades.

-->

Services

Equity Investment with CA Abhay

Stock Market Masterclass

FNO Stocks with CA Abhay

Option Trading with CA Abhay

Equity Trading with CA Abhay

onlyfans leakedonlyfan leaksonlyfans leaked videos